• Molecular NameUdenafil
  • SynonymNA
  • Weight516.667
  • Drugbank_IDDB06267
  • ACS_NO268203-93-6
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.48
  • pkaN/A
  • LogD (pH=7, predicted)0.8
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.33
  • LogSw (predicted, AB/LogsW2.0)0.07
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors2
  • No.of HBond Acceptors10
  • No.of Rotatable Bonds11
  • TPSA126.3
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug used in urology to treat erectile dysfunction. It belongs to a class of drugs called PDE5 inhibitor, which many other erectile dysfunction drugs such as sildenafil, tadalafil, and vardenafil also belong to.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic. Metabolized by CYP3A4 and CYP3A5.
  • Half life7.3~12.1 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A